SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 

Back on track: Strong Q2 balances out natural colours loss for Chr. Hansen

By Nathan Gray+

09-Apr-2014
Last updated on 09-Apr-2014 at 14:06 GMT2014-04-09T14:06:17Z

Chr. Hansen year to date: Strong Q2 eases colour customer losss

Ingredients giant Chr. Hansen has an unchanged outlook for full year, after a strong second quarter eased the woes created by the firm losing its biggest colours customer in Q4 last year.

The Danish food and nutritional ingredients company reported revenue of €353 million for the year to date (H1 2013/14) with organic growth at 6% overall. EBITDA was up 1.8% to €113.7m, said the firm.

Speaking to FoodNavigator, Chr. Hansen CFO Klaus Pedersen said strong growth in cultures and enzymes throughout Q2 has helped to ease the impact brought on by the firm losing its biggest colours customer in Q4 of the previous year - which had impacted the firm significantly in Q1 .

Looking forward to the full year expectations, Pedersen said: "The customer loss impact will not be that significant in Q4, so that will tail off, and furthermore with a very strong performance in Q2 we believe there is a very good chance of us reaching our goal."

He added that for the full-year, the expectation continues to be organic growth of 7-9% and an operating margin above 26%.

"Our strategy says 7-10% planned organic growth for each year, and when we said 7-9% for this year that was exactly because we said that with the impact of the colour customer loss we cannot to 10% this year - 7-9% is more realistic."

Colours down, but not out

The Danish ingredients firm saw revenue from its natural colours division drop by 9% to €74m - with the division accounting for 21% of revenue, down from 23% of revenue in the same period last year.

The customer loss, which led to an 8% loss of organic growth in the division, has since been offset somewhat by good growth in the remaining business of the division - especially within FruitMax, colour blends, and carmine products, said the firm.

Indeed, Pedersen said the customer loss has impacted the colours business by between 7 and 8% in the first half of the year - adding that he expects to the negative impact towards colours growth in Q3 too.

Discounting the strong impact of the loss, coupled with impact that carmine prices are having on global businesses, he said that the colours division witnessed around 7% to 8% growth in other areas.

"We have an expectation of doing 10%, so it's not living up to our expectations, and the main reason for that is that in the Chinese colours market, we have not really got the momentum that we would like to see."

"We are not light years away from where we want to be, but we need to take it from between 7 and 8%, up to about 10%."

However, Pedersen admitted that for the year full year 14, the division would not reach its target of double digit growth - conceding that the impact of the customer loss is simply too big to catch up the losses and grow 10% on top in one financial year.

"But we believe that in the coming quarters we will revert to positive growth," he said.

Enzymes and cultures grown, despite probiotic downturn

Pedersen commented that growth in cultures and enzymes had been very strong in Q2, and has set up for the firm to meet and perhaps exceed expectations of around 10% grown in the area at full year.

"Obviously when we did 12% in Q2, that is a quarter where we succeeded in almost all product areas, from fermented meat to cheese and cultures, and also enzyme solutions. And from a geographical point of view that was also really well distributed," said the Chr. Hansen CFO.

"The only weakness in this division, as we see, is that the probiotic market in Europe continues to go down after the extra regulations came in to place."

Indeed, he said that the slow-down in probiotics has seen the category 'cannibalised' by other yoghurt categories, meaning a further decline will be expected in coming quarters.

"It's a testament to us not being too dependent on probiotics, in the sense that if we see the market growing in Greek yoghurt, or high protein or low fat yoghurts; it doesn't really make such a big difference for us.

"In essence what you are seeing is the cannibalisation of one category, but that it is benefiting other categories, and we are also well established in the other categories."

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars